NCT01958593 - Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 14, 2014

Primary Completion Date

September 10, 2015

Study Completion Date

October 17, 2016

Conditions

Posttraumatic Stress Disorder

Interventions

DRUG

Placebo

Placebo with therapy administered in two blinded experimental sessions. Participants in this group in Stage 1 may take part in Stage 2.

DRUG

Midomafetamine HCl

Participants will receive MDMA-assisted therapy during two blinded experimental sessions. After unblinding, may receive a third session of open-label MDMA-assisted therapy.

BEHAVIORAL

Psychotherapy

Psychotherapy before and after experimental sessions.

Trial Locations (1)

V6R 1N6

Offices of Dr. Ingrid Pacey MBBS FRCP[C], Vancouver